{"slideshow_credits": null, "snippet": "With rare exceptions, it is hard to think of a single truly novel psychotropic drug that has emerged in the last 30 years.", "abstract": "Production of new psychiatric drugs has slowed as manufacturers, seeming to view development of new drugs as risky and expensive, create medications that are essentially copies of one another; underlying the shortage is fact that brain is uniquely difficult to study and understand.", "section_name": "Health", "print_page": "3", "document_type": "article", "byline": {"person": [{"lastname": "FRIEDMAN", "qualifier": "M.D", "rank": 1, "firstname": "Richard", "role": "reported", "organization": "", "middlename": "A."}], "original": "By RICHARD A. FRIEDMAN, M.D", "contributor": ""}, "web_url": "http://www.nytimes.com/2013/08/20/health/a-dry-pipeline-for-psychiatric-drugs.html", "lead_paragraph": "With rare exceptions, it is hard to think of a single truly novel psychotropic drug that has emerged in the last 30 years.", "headline": {"main": "A Dry Pipeline for Psychiatric Drugs", "print_headline": "A Dry Pipeline for Psychiatric Drugs", "content_kicker": "Mind", "kicker": "Mind"}, "_id": "5220a87c38f0d8740ac9ad01", "word_count": "936", "multimedia": [{"height": 126, "url": "images/2013/08/20/science/20MIND_SPAN/20MIND-thumbWide.jpg", "legacy": {"wideheight": "126", "wide": "images/2013/08/20/science/20MIND_SPAN/20MIND-thumbWide.jpg", "widewidth": "190"}, "subtype": "wide", "width": 190, "type": "image"}, {"height": 400, "url": "images/2013/08/20/science/20MIND_SPAN/20MIND-articleLarge.jpg", "legacy": {"xlarge": "images/2013/08/20/science/20MIND_SPAN/20MIND-articleLarge.jpg", "xlargewidth": "600", "xlargeheight": "400"}, "subtype": "xlarge", "width": 600, "type": "image"}, {"height": 75, "url": "images/2013/08/20/science/20MIND_SPAN/20MIND-thumbStandard.jpg", "legacy": {"thumbnail": "images/2013/08/20/science/20MIND_SPAN/20MIND-thumbStandard.jpg", "thumbnailwidth": "75", "thumbnailheight": "75"}, "subtype": "thumbnail", "width": 75, "type": "image"}], "pub_date": "2013-08-20T00:00:00Z", "source": "The New York Times", "news_desk": "Science", "keywords": [{"value": "Mental Health and Disorders", "name": "subject", "is_major": "Y", "rank": "3"}, {"value": "Drugs (Pharmaceuticals)", "name": "subject", "is_major": "Y", "rank": "1"}, {"value": "Depression (Mental)", "name": "subject", "is_major": "N", "rank": "2"}, {"value": "Medicine and Health", "name": "subject", "is_major": "N", "rank": "4"}], "blog": [], "subsection_name": null, "type_of_material": "News"}